PIQ 1.12% 88.5¢ proteomics international laboratories ltd

Ann: Sonic Healthcare USA signs licence for PromarkerD in the US, page-68

  1. 144 Posts.
    lightbulb Created with Sketch. 18
    Major kidney study 'FLOW' stopped 1 year early due to overwhelmingly positive results. The study is evaluating the effect of medication Semagutide commonly known as Ozempic on the progression of diabetic kidney disease.

    Major kidney study 'FLOW' stopped 1year early due to overwhelmingly positive results. The study isevaluating the affect of medication Semaglutide, commonly known as Ozempic, onthe progression of kidney disease, results of the study are expected to be publishedearly in

    Majr kidney study 'FLOW' stopped 1year early due to overwhelmingly positive results. The study isevaluating the affect of medication SeMmaglutide, commonly known as Ozempic, onthe progression of kidney disease, results of the study are expected to be publishedearly in 2024.





    https://www.everydayhealth.com/kidney-diseases/ozempic-is-so-beneficial-for-kidney-health-they-just-stopped-a-major-trial-one-year-early/?_cldee=PBfE3K3FNFT_iiB41V8_0mfDQG5lPHkSfH_uvZCvR2xi451-VgCWtUIQhC91hlOn&recipientid=contact-be4d77e92348ec118c62002248159d41-6d8e2db6bb7943ce8097279d979b29bf&esid=fd7b33d7-d26b-ee11-9ae7-000d3a798fb7
 
watchlist Created with Sketch. Add PIQ (ASX) to my watchlist
(20min delay)
Last
88.5¢
Change
-0.010(1.12%)
Mkt cap ! $115.8M
Open High Low Value Volume
89.0¢ 89.0¢ 84.0¢ $456.0K 523.4K

Buyers (Bids)

No. Vol. Price($)
1 5797 87.0¢
 

Sellers (Offers)

Price($) Vol. No.
88.5¢ 74306 1
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
PIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.